The pediatric randomized carvedilol trial in children with chronic heart failure: Rationale and design
Authors:
- Robert E. ShaddyRSRobert E. Shaddy
- E.Leigh CurtinECE.Leigh Curtin
- Brett SowerBSBrett Sower
- Lloyd Y. TaniLTLloyd Y. Tani
- Jeri BurrJBJeri Burr
- Bernard LaSalleBLBernard LaSalle
- Mark M. BoucekMBMark M. Boucek
- Lynn MahonyLMLynn Mahony
- Daphne T. HsuDHDaphne T. Hsu
- Elfriede PahlEPElfriede Pahl
- Grant H. BurchGBGrant H. Burch
- Rozsa Schlencker-HercegRSRozsa Schlencker-Herceg
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 144 (3) , 383-389
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Carvedilol as therapy in pediatric heart failure: An initial multicenter experienceThe Journal of Pediatrics, 2001
- Differential Effects of β-Blockers in Patients With Heart FailureCirculation, 2000
- Pediatric ResearchAmerican Journal of Therapeutics, 1999
- Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular DysfunctionCirculation, 1999
- β-Blocker therapy in young children with congestive heart failure under consideration for heart transplantationAmerican Heart Journal, 1998
- Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patientsAmerican Heart Journal, 1995
- Grading the severity of congestive heart failure in infantsPediatric Cardiology, 1992